Heather Brand, PharmD, MSPBA Candidate

The concept of specialty at retail has the potential to unlock vast financial, contracted volume, and patient continuum of care opportunities attached to pharmaceutical products currently dispensed in specialty pharmacies.

Outcomes-based contracting may soon play a role in the service level agreements between a specialty pharmacy provider and a manufacturer.

The current outlook for biosimilar manufacturers shows significant promise.

How to evaluate quality in pharmacies that offer distinct services to complex disease states, such as HIV, hemophilia, and oncology.

Patient satisfaction and coordination of care are vital to the success of a high cost specialty drug regimen.

Payers and manufacturers must ensure patients are getting the most value from their therapy.

Improved outcomes can position a specialty pharmacy to capitalize on projected specialty drug growth.